pharmaphorum

OCTOBER 13, 2021

8+ years proven work experience as a managing editor, ideally web content. The post Editor (Deep Dive) appeared first on. Qualifications and Experience. BSc/BA in journalism or relevant field. 5+ years working within pharmaceutical industry or healthcare environment.

People Management 52

People Management Communication 52

Fierce Healthcare

JANUARY 31, 2022

Editor's Corner: Fierce Healthcare gets a fierce makeover. Mon, 01/31/2022 - 10:47.

98

98

Fierce Healthcare

OCTOBER 14, 2021

Editor's Corner—Medicare Advantage open enrollment opens today. Hear top industry execs discuss the trends to watch. Thu, 10/14/2021 - 12:41.

132

132

pharmaphorum

OCTOBER 13, 2021

The web editor is responsible for driving the editorial strategy and content plan (excluding the news channel) for pharmaphorum.com through engaging with the editorial team / freelancers / external partners to develop and execute high quality content for the website and its associated publications. The post Web Editor appeared first on.

Communication 40

Communication 40

Fierce Healthcare

DECEMBER 21, 2023

Physician pay and workforce issues were top of mind for Fierce Healthcare readers in 2023. Physician pay and workforce issues were top of mind for Fierce Healthcare readers in 2023.

Hospitals 121

Hospitals 121

Fierce Healthcare

DECEMBER 20, 2023

Among our most-read stories of the year, one topic clearly rose to the top: Medicare Advantage. Many of the most-read health insurance stories from Fierce Healthcare in 2023 center on Medicare Advantage.

Insurance 114

Insurance 114

STAT

APRIL 13, 2024

STAT publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay.

102

102

STAT

MARCH 9, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay.

132

132

Fierce Pharma

APRIL 19, 2024

This week on “The Top Line,” we're joined by Fierce Biotech Senior Editor Annalee Armstrong and Fierce Pharma Marketing Senior Editor Ben Adams.

94

94

STAT

APRIL 20, 2024

STAT publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay.

Hospitals 78

Hospitals 78

STAT

NOVEMBER 14, 2023

I want to bring your attention to a vitally important  investigation  STAT has published today. For more than a year, our reporters have documented how the use of artificial intelligence is driving denial of claims or delaying treatment for seriously ill patients.

Health Insurance Companies 117

Health Insurance Companies Documentation Insurance 117

STAT

APRIL 2, 2024

Verve Therapeutics said Tuesday that it is pausing testing of its closely watched gene-editing treatment for high cholesterol after a patient receiving the drug experienced elevated liver enzymes and low platelet levels.

Compounding 106

Compounding 106

STAT

APRIL 6, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay. “For national security, the U.S.

84

84

pharmaphorum

APRIL 4, 2024

Last week, pharmaphorum editor-in-chief Jonah Comstock travelled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host and Deep Dive editor Eloise McLellan about his biggest takeaways from the two-day event.

102

102

Pharmaceutical Technology

JANUARY 29, 2024

An eye-catching milestone in hand, Ascidian will begin the Phase I/II STELLAR study of ACDN-01 for Stargardt disease in H1 2024.

104

104

Pharmaceutical Commerce

APRIL 19, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Environtainer, suggests how to improve visibility and risk management for cold chain shipping.

106

106

STAT

FEBRUARY 10, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay.

FDA 96

FDA 96

pharmaphorum

JANUARY 11, 2022

Healthware has appointed Jonah Comstock as editor-in-chief to further growth and expansion of the Group’s Media and Community business which aims at fostering the dialogue and the connections among the digital health community helping industry, policymakers, and physicians to embrace the digital transformation of health.

Communication 52

Communication 52

Pharmaceutical Commerce

APRIL 23, 2024

In an interview with Pharma Commerce Associate Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, talks themes of this year's event and future plans for the show.

93

93

STAT

NOVEMBER 4, 2023

Today STAT turns 8.

Documentation 131

Documentation 131

STAT

JANUARY 6, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay.

101

101

STAT

FEBRUARY 17, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay. “ Dental care is in crisis.

86

86

Fierce Healthcare

DECEMBER 22, 2021

Editor's corner: Fierce Health IT's 10 most read stories of 2021 tracked Google, Amazon and the investment boom. Wed, 12/22/2021 - 13:56.

58

58

STAT

DECEMBER 23, 2023

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay.

FDA 95

FDA 95

STAT

DECEMBER 9, 2023

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay.

96

96

pharmaphorum

DECEMBER 14, 2021

Can the ryze visual Define-XML editor make it quick and easy? What are the benefits of using the Formedix ryze Visual Define-XML Editor? The post How the Formedix ryze Visual Define-XML Editor Gives You Faster Define appeared first on. There’s no manual work. And there’s no programming involved. Get in touch with Formedix!

FDA 52

FDA 52

Fierce Healthcare

DECEMBER 22, 2021

Editor's corner: Fierce Healthcare's 10 most read stories tracked COVID, vax mandates and megadeals. Wed, 12/22/2021 - 11:54.

52

52

STAT

JUNE 27, 2023

Dear Readers, Today is an important day in the history of STAT: We have refreshed the look of our homepage and adjusted the teal color that has been synonymous with STAT since we launched nearly eight years ago. Read the rest…

94

94

STAT

JANUARY 13, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay. “ Pumping milk at JPM was a nightmare.

Insurance 88

Insurance 88

STAT

DECEMBER 2, 2023

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay.

95

95

Pharmaceutical Commerce

APRIL 8, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features.

106

106

STAT

MARCH 6, 2023

Dear Readers, Let me call your attention to an important new series at STAT: “The Obesity Revolution.” ” Over the coming days and months, we’ll examine a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

75

75

STAT

MARCH 14, 2023

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields. There were, of course, many contenders to choose from.

82

82

Pharmaceutical Commerce

APRIL 5, 2024

In an interwith with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory, explains why pharmaceutical products tend to cost more in the US than the rest of the world.

106

106

STAT

DECEMBER 29, 2022

Dear Reader, From STAT’s first investigations in June 2021 revealing why the FDA gave the go-ahead for a marginally effective Alzheimer’s drug manufactured by Biogen, we have relentlessly stayed on the story.

FDA 78

FDA 78

Fierce Healthcare

DECEMBER 22, 2021

Editor's corner: Fierce Health Payer's top 10 stories of 2021. Wed, 12/22/2021 - 13:40.

45

45

pharmaphorum

APRIL 18, 2024

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.

103

103